Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MDxHealth SA - Ordinary Shares (NQ:MDXH)

0.7838 +0.0338 (+4.51%)
Streaming Delayed Price Updated: 12:42 PM EDT, May 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MDxHealth SA - Ordinary Shares

< Previous 1 2 3 4 Next >
These stocks have an unusual volume in today's session ↗
Via Chartmill
7,500 Done. AI Has Moved the Goalposts. ↗
Via Chartmill
Topics Artificial Intelligence
These stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Which stocks are gapping on Thursday? ↗
Via Chartmill
MDxHealth (NASDAQ:MDXH) Reports Mixed Q4 2025 Results, Misses Revenue Estimates ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
Insights Ahead: MDxHealth's Quarterly Earnings ↗
 
Via Benzinga
Discover the top movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
MDxHealth (MDXH) Q1 2026 Earnings Transcript ↗
MDxHealth (MDXH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
MDxHealth Q1 Earnings Call Highlights ↗
MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas,... 
Via MarketBeat
Topics Earnings
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Mdxhealth Reports Q1-2026 Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript ↗
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
From mdxhealth
Via GlobeNewswire
News headline image
MDxHealth (MDXH) Q3 2025 Earnings Call Transcript ↗
MDxHealth (MDXH) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MDxHealth (NASDAQ:MDXH) Reports Mixed Q3 2025 Results, Achieves Key Profitability Milestone ↗
MDxHealth reported mixed Q3 2025 results with 18% revenue growth and a key milestone of positive adjusted EBITDA, despite missing top-line estimates. 
Via Chartmill
News headline image
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
From mdxhealth
Via GlobeNewswire
News headline image
A Glimpse of MDxHealth's Earnings Potential ↗
 
Via Benzinga
News headline image
MDXHEALTH (NASDAQ:MDXH) Shows Strong Technical and Fundamental Growth Momentum ↗
MDxHealth (MDXH) stock shows strong technical uptrend and fundamental growth momentum, meeting criteria for high-growth investors. 
Via Chartmill
News headline image
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
From mdxhealth
Via GlobeNewswire
News headline image
Introducing the Master Swing Trading Course: Built From Your Questions, Backed by 30+ Years of Experience ↗
After months of work, we’re proud to release the Master Swing Trading Course - a 175-page deep dive designed from your feedback and our three decades of market experience. 
Via Chartmill
News headline image
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
From mdxhealth
Via GlobeNewswire
News headline image
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
From mdxhealth
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.